CON: Should patients with nonalcoholic steatohepatitis fibrosis undergo bariatric surgery as a primary treatment?
Eric B. Newton, Jason Pan, Waihong Chung – 21 July 2022
Emerging liquid biopsy techniques for early detection of hepatocellular carcinoma, prognostication, and disease monitoring
Ashwini Arvind, Amit G. Singal – 21 July 2022
Overview of autoimmune liver disease: Prevalence, risk factors, and role of autoantibodies
Dong Xi, Henry Lin, Amit A. Shah – 21 July 2022
Diagnosis and management of hepatic encephalopathy: A summary for patients
Ellen W. Green, Arnab Mitra – 21 July 2022
Reply
Laurens A. Kleef, Milan J. Sonneveld, Robert J. Knegt – 20 July 2022
Acute hepatitis of unknown origin in children: Behind the statistics
Randa Elsheikh, Hoang Thuy Tien, Abdelrahman M. Makram, Nguyen Thanh Van, Trang Thi Bich Le, Tamilarasy Vasanthakumaran, Nguyen Tien Huy – 20 July 2022 – Since April 2022, the world has been witnessing a rapidly spreading outbreak of acute hepatitis of unknown origin in children < 16 years old that has affected several countries around the world. Most of the cases have presented with the clinical picture of severe hepatitis that has led to resorting to liver transplantation in several cases.
Reply
Kwang Yoon Kim, Kyung‐Won Hong, Bom Taeck Kim – 20 July 2022
Reply
Dong Hyun Sinn, Danbee Kang, Eliseo Guallar, Juhee Cho, Geum‐Youn Gwak – 20 July 2022
Hepatocyte β‐catenin loss is compensated by Insulin‐mTORC1 activation to promote liver regeneration
Shikai Hu, Catherine Cao, Minakshi Poddar, Evan Delgado, Sucha Singh, Anya Singh‐Varma, Donna Beer Stolz, Aaron Bell, Satdarshan P. Monga – 20 July 2022
Polycystic ovary syndrome is associated with nonalcoholic steatohepatitis in women of reproductive age
Stephanie S. Maldonado, Joshua Grab, Connie W. Wang, Heather Huddleston, Marcelle Cedars, Monika Sarkar – 20 July 2022 – Polycystic ovary syndrome (PCOS) occurs in approximately 10% of all reproductive‐age women, with over 50% of these patients having imaging‐confirmed nonalcoholic fatty liver disease (NAFLD). Whether PCOS increases the risk for more clinically relevant disease, such as nonalcoholic steatohepatitis (NASH), is unclear. Such findings are relevant to prognosticating risk of progressive liver disease in the growing population of young adults with NAFLD.